| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.27 | 6e-09 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |